A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight

NCT05813925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

331

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity or Overweight

Interventions

DRUG: Cagrilintide
DRUG: Semaglutide
DRUG: Placebo Semaglutide

Sponsor

Novo Nordisk A/S